| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Regular Articles |
Department of Radiation Oncology, Sunnybrook and Womens College Health Sciences Center, University of Toronto, Toronto, Ontario, M4N 3M5 Canada [Y-Q. L., C. S. W.]; Division of Nuclear Medicine, Toronto General Hospital, University Health Network, University of Toronto, Toronto, Ontario, M5G 2C4 Canada [P. C., R. M. R.]; and Memorial Sloan-Kettering Cancer Center, New York, New York 10021 [A. H-F.]
| ABSTRACT |
|---|
|
|
|---|
| INTRODUCTION |
|---|
|
|
|---|
Although not as well defined in the CNS, acute vascular changes such as endothelial cell swelling, thickening of the basal lamina, vasculation of cytoplasm, vascular permeability, and edema have been observed within 24 h after XRT (10) . In the CNS, the endothelial cell, strengthened by tight junctions and having low rates of fluid-phase endocytosis, defines the BBB (11) . Disruption of the BBB is consistently observed at early times after XRT. Using Evans blue dye as a vascular tracer, Siegal et al. (4) demonstrated an increase in vascular permeability at 18 h after a single dose of 15 Gy. This was associated with a decrease in levels of endothelin, a potent vasoconstrictor.
Microvascular endothelial apoptosis has been demonstrated to play a critical role in XRT pneumonitis (12) and, more recently, in XRT-induced crypt damage and death from the gastrointestinal syndrome (13) . Endothelial apoptosis has been observed within 24 h after XRT in the CNS (2) . In rat brain, a single dose of 25100 Gy produced a 15% loss of endothelial cells within 24 h (14) . This was consistent with endothelial cell apoptosis observed during the first 24 h after XRT.
In vitro and in vivo, XRT-induced endothelial cell apoptosis is mediated by the lipid second messenger ceramide via activation of ASMase (15 , 16) . This pathway is initiated by the hydrolysis of sphingomyelin via the action of sphingomyelinases to generate ceramide. Ceramide then serves as a second messenger in this system, leading to apoptosis (17) . Sphingomyelin degradation has been ascribed to at least two distinct sphingomyelinases: ASMase, and NSMase. Both ASMase and NSMase have been implicated in radiation-induced apoptosis (18, 19, 20) . Recent investigations linked the activation of ASMase to the stress-activated protein kinase/c-jun kinase cascade and apoptotic responses, and NSMase to the extracellular signal-regulated kinase cascade and pro-inflammatory responses (21 , 22) . XRT-induced apoptosis was found to be defective in endothelial cells of ASMase -/- mice, suggesting that the activation of ASMase plays a critical role in XRT-induced apoptosis (2 , 13 , 23) . However, whether apoptotic damage to the microvasculature plays a role in the pathogenesis of acute XRT damage to the CNS remains unclear.
We postulated that the acute loss of endothelial cells is associated with endothelial cell apoptosis. We further postulated that endothelial cell apoptosis leads to acute disruption of the BBB. In this study, we demonstrate a reduction in endothelial cell density and disruption of the BSCB in wild-type but not ASMase knockout animals. These results are thus consistent with the hypothesis that there is a causal relationship between acute endothelial cell apoptosis and BBB disruption and that the ASMase pathway plays a critical role in acute BBB disruption in the CNS after XRT.
| MATERIALS AND METHODS |
|---|
|
|
|---|
Irradiation.
Animals were immobilized during XRT in a polystyrene foam jig and with inhalation anesthesia with halothane. The cervical spinal cord (C2T2) was irradiated by two Picker Gemini 100-kV X-ray units used in a parallel, opposed configuration. Check films for accuracy of field placement and in vivo thermoluminescence dosimetry were performed before the experiments. Details of XRT methods were as described previously (25)
.
Rats were irradiated with a single dose of 0, 2, 8, 19.5, 22, 30, or 50 Gy. Single doses of 19.5 and 22 Gy represented the ED50 and ED100, respectively, for forelimb paralysis within 180 days secondary to white matter necrosis in the rat spinal cord model (25) . A much higher radiation dose was required to induce paralysis in mice, and studies in mice yielded ED50 doses of 4655 Gy for myelopathy (26, 27, 28) . Transgenic mice were thus irradiated with a single dose of 50 Gy. Control rats and mice were not irradiated. A minimum of three animals were used at each experimental time point, unless otherwise indicated.
Histopathology.
Animals were anesthetized with i.p. ketamine (Bimeda-MTC Animal Health Inc., Cambridge, Ontario, Canada) at 0.075 ml/100 g of body weight and Rompun (Bayer Inc., Toronto, Ontario, Canada) at 0.03 ml/100 g dissolved in sterilized physiological saline. After a 1-min transcardiac perfusion with 0.9% saline to clear blood from the circulatory system, animals were perfused with a 10-min transcardiac infusion of 10% buffered-neutral formalin. The spinal cord was dissected out, and sections were obtained by cutting the spinal cord transversely at mid-plane between C2 and T2. Specimens were processed by a standard paraffin embedding method between 48 and 72 h after XRT and cut at 4-µm thickness for routine H&E and immunohistochemical studies.
Assessment of Apoptosis.
For assessment of apoptosis, animals were sacrificed at 8 or 10 h after XRT. Identification of apoptotic cells was based on standard morphological criteria under light microscopy at x1000 magnification on H&E-stained sections as described previously (1
, 7)
. Briefly, cells that showed cell shrinkage and nuclear condensation or fragmentation were considered apoptotic cells, and apoptotic cells on vascular microvessel walls or inside microvessels were considered vascular endothelial cells undergoing XRT-induced apoptosis. Selected slides were processed for TUNEL with use of the In situ Cell Death Detection Kit (Boehringer Mannheim Canada, Laval, Québec, Canada). As described previously (1
, 29)
, deparaffinized sections were incubated with proteinase K and were sequentially incubated with TUNEL reaction mixture (Boehringer Mannheim Canada) after washing in PBS. The tagged ends were labeled with an antibody conjugated to FITC (Dako Diagnostics Canada Inc., Mississauga, Ontario, Canada). The sections were then stained with laminin conjugated with Cy3 (Sigma, St. Louis, MO) and counterstained with DAPI (Sigma) to further confirm apoptotic endothelial cells. The microscopic filter used for TUNEL staining was temporarily changed when a TUNEL-positive cell was observed during counting to determine whether there was nuclear condensation or fragmentation in DAPI staining to avoid TUNEL false positive staining, i.e., artifact.
Immunohistochemistry.
Sections were deparaffinized in toluene and rehydrated through a graded alcohol series. Endogenous peroxidase activity was blocked in 3% H2O2. After pretreatment with pepsin for albumin (Biogenesis Inc., Poole, England), laminin (Sigma), and factor VIII-related antigen (Dako Diagnostics Canada) immunohistochemistry, the sections were incubated with the respective primary antibodies (1:6400 dilution for albumin, 1:200 dilution for laminin, and 1:2000 dilution for factor VIII-related antigen). This was followed by incubations with biotinylated linking antibody and horseradish peroxidase (Dako Diagnostics Canada) with brief rinses in PBS between incubations. The reaction was visualized using 3-amino-9-ethylcarbazole, or NovaRED (Vector Laboratories, Burlingame, CA) and counterstained with Mayers hematoxylin. Reagent controls (omitting the primary antibody or substituting nonimmune serum for the primary antibody in the staining protocol) on tissue sections revealed no staining, thus confirming the specificity of the primary antibodies used.
Assessment of BSCB Permeability.
BSCB permeability was assessed by use of immunohistochemistry for albumin in the CNS parenchyma as a surrogate for disruption of the BSCB (30)
, and BSCB breakdown was assessed semiquantitatively by use of a MicroComputer Image Device (Imaging Research, Inc., St. Catherine, Ontario, Canada; Ref. 31
).
Evans blue dye was applied as a second method to confirm BSCB disruption in the irradiated spinal cord after XRT. Evans blue dye is an azo dye that binds with high affinity to albumin and has intense red fluorescence under rhodamine optics. Evaluation of BSCB breakdown by use of Evans blue dye was based on the method described previously by Fullerton et al. (32) . Briefly, 200 µl of 4% (w/v) Evans blue (Sigma) in 0.9% saline were injected i.v., and the animals were anesthetized and perfused with 20 ml of PBS and then 20 ml of 4% paraformaldehyde in PBS at 24 h after XRT, or 1 h after Evans blue injection. Tissues were immersed in 30% sucrose in PBS for at least 48 h and embedded in Frozen Tissue Embedding Media (Fisher Scientific, Fair Lawn, NJ). A series of cryostat sections of 10-µm thickness were obtained by cutting the spinal cord transversely at mid-plane between C2 and T2, and BSCB leakage was evaluated at x1000 magnification under fluorescent microscopy (Leica LUX S; Leica Microsystems, Wetzlar, Germany).
The BBB/BSCB permeability tracer 99mTc-DTPA was used to assess BSCB breakdown quantitatively. 99mTc-DTPA was prepared by the addition of Na99mTcO4 (Technelite generator; DuPont Pharma, Billerica, MA) and saline to the DTPA-Plus kit (Draximage, Montreal, Québec, Canada). The specificity of 99mTc-DTPA at injection was 5075 MBq/mg, and radiochemical purity was >95% as confirmed by thin-layer chromatography.
Mice that were +/+, +/-, or -/- for ASMase received i.v. injections containing 2 MBq of 99mTc-DTPA at 23 h after the 50-Gy dose. At 24 h after XRT, i.e., 1 h after 99mTc-DTPA injection, they were sacrificed, blood samples were obtained from the heart, and the segment of the spinal cord (C2T2) was dissected. Blood and the spinal cord samples were weighed and counted for 99mTc immediately along with a standard in a gamma counter. Results were expressed as the percentage of the injected dose per gram of tissue and spinal cord-to-blood ratios.
Morphometry.
Microvessels that had been cut in transverse sections were analyzed morphometrically. Microvessels only were chosen for analysis because they represent 95% of the bloodtissue interface (33)
; they were defined as vessels composed of one endothelial cell and basement membrane that was positive for laminin. Microvessels were considered to have been cut transversely if the cell membranes were in sharp focus around the entire circumference and if the ratio of the largest diameter to the smallest diameter was <1.5 (33
, 34)
. Two parameters were used to define endothelial and microvessel density changes in the spinal cord after XRT: (a) endothelial cell density, defined as that the total number of endothelial cells that contained a nucleus divided by the transverse cross-sectional area of the spinal cord; and (b) microvessel density, defined as that the total number of microvessels that had been transversely sectioned and contained either endothelial cell nucleus or no nucleus, divided by the transverse cross-sectional area of the spinal cord.
Statistical Analysis.
All data represent the mean ± SE. Statistical significance was determined by Students t test, except that the MannWhitney test was used to determine whether there was a change in endothelial cell density at various time intervals after XRT compared with nonirradiated controls. Data were considered statistically significant at P < 0.05. All statistical tests were two-sided. A correlation analysis was used to assess whether there was a doseresponse relationship for endothelial cell loss after XRT.
| RESULTS |
|---|
|
|
|---|
|
|
0.7 apoptotic cells/section) and no evidence of endothelial apoptosis. An increase in the number of endothelial apoptosis was observed at 8 h after a single dose of 50 Gy compared with the same genotype controls (Table 1)
|
|
Early BSCB Disruption after XRT Is Mediated by the ASMase Pathway.
To investigate whether BSCB disruption is mediated by the ASMase pathway, we assessed BSCB permeability in ASMase +/+, +/-, and -/- mouse spinal cord at 24 h after a 50-Gy dose (Fig. 4)
. In nonirradiated spinal cord of ASMase +/+ mice (Fig. 4, A and E)
, no albumin staining was evident, but diffuse albumin staining was observed after a single dose of 50 Gy (Fig. 4, B and F)
. Albumin staining was not evident in nonirradiated (Fig. 4, C and G)
or irradiated ASMase -/- mice (Fig. 4, D and H)
.
|
To provide a quantitative assessment of BSCB permeability changes in the three genotypes of ASMase mice, we measured activity for 99mTc-DTPA in the spinal cord at 24 h after a single dose of 50 Gy (Fig. 5)
. There was no evidence of 99mTc-DTPA accumulation in the spinal cord of ASMase -/- mice after XRT. ASMase +/- animals showed an intermediate response compared with that observed in ASMase +/+ and -/- animals. Significant difference in the activity of 99mTc-DTPA in the spinal cord was observed between irradiated ASMase +/+ animals and nonirradiated controls (P = 0.025; Fig. 5A
). Similar results were seen when we used the spinal cord-to-blood ratio of detected 99mTc-DTPA (P < 0.01; Fig. 5B
).
|
| DISCUSSION |
|---|
|
|
|---|
In nonirradiated mouse or rat spinal cord, spontaneous apoptosis was a rare event. After XRT, apoptotic cells were occasionally observed on the microvessel wall or within microvessels when we used specific immunohistochemical vascular markers and the TUNEL assay, indicating that certain vascular endothelial cells in the CNS were undergoing XRT-induced apoptosis. A significant increase in the number of endothelial apoptosis was observed at 8 h after a single dose of 50 Gy. The apoptotic response of endothelial cells at 8 h in the ASMase +/- animals appeared intermediate compared with that seen in ASMase +/+ and -/- animals. These observations are consistent with previous investigation by Peña et al. (2) , suggesting that XRT-induced endothelial apoptosis in the CNS is regulated by the ASMase pathway.
In the present study, a decrease in endothelial cell density was noted at 24 h after XRT in both mouse and rat spinal cord. A 15% loss of endothelial cells in rat brain within 1 day after doses of 25100 Gy was reported previously by Ljubimova et al. (14) . In ASMase +/+ mouse spinal cord, the density of endothelial cells showed an almost 50% reduction at 24 h after a 50-Gy dose. The reduction in endothelial cell density observed here in ASMase +/+ mouse spinal cord was greater than that observed in rat brain after XRT. This difference may in part be attributable to methodological differences, i.e., different staining used to identify microvessels and different criteria used for counting endothelial cells. It might also be influenced by differences in species and tissues.
The early decrease in the number of endothelial cells has been postulated to be attributable to apoptosis of a part of the endothelial population after XRT (2) . Our results of a gradual decline in endothelial cell density beginning at 8 or 10 h after XRT were consistent with this notion. In ASMase +/+ mouse spinal cord, there was an almost 50% reduction in endothelial cell density at 24 h after 50 Gy, but no decrease was seen in ASMase -/- mice. Results from this genetic model thus provide definitive proof linking the loss of endothelial cell density to endothelial apoptosis after XRT.
Similar to the results of Peña et al. (2) , in the present study the apoptotic endothelial cells represented only a small component of the cells undergoing apoptosis after XRT. It is interesting to note that this led to a significant reduction in the endothelial cell population at 24 h after XRT. We have previously shown that the presence of a few apoptotic oligodendrocytes after XRT is also associated with a significant reduction in oligodendroglial density at 24 h after XRT (1) . This is consistent with the notion of the very short duration of the apoptotic process in vivo (35) . For apoptotic endothelial cells, the present methods might also underestimate the actual number of endothelial cells undergoing XRT-induced apoptosis because dying cells shrinking and dislodging away from microvessel walls could be washed away by the blood stream. Moreover, the perfusion procedure used for clearing blood from the circulatory system and tissue fixation in the present study might also wash away some apoptotic endothelial cells and would further limit the detection of apoptotic endothelial cells.
This is the first study demonstrating that endothelial apoptosis is causally associated with acute BSCB disruption after XRT. We observed a dose-dependent reduction in endothelial cell density at 24 h after XRT, which was associated with a similar dose-dependent disruption in BSCB as demonstrated by albumin immunohistochemistry. The dependence of XRT-induced apoptosis of endothelial cells on the ASMase pathway provided us with a genetic approach to address the molecular mechanism of acute BBB disruption induced by XRT. Whereas an almost 50% reduction in endothelial cell density was observed in ASMase +/+ mouse spinal cord at 24 h after a 50-Gy dose, we observed no decrease in ASMase -/- mice. BSCB leakage was evident at 24 h after a 50-Gy dose in ASMase +/+ mouse spinal cord but not in nonirradiated controls and irradiated ASMase -/- mice. These observations provide compelling evidence that XRT-induced endothelial cell apoptosis is causally associated with the acute BSCB disruption after XRT.
We previously demonstrated that oligodendroglial apoptosis after XRT was p53 dependent (36) . The reduction in endothelial cell density at 24 h after a 50-Gy dose in p53 +/+ mouse spinal cord was similar to that observed in p53 -/- animals. Consistent with the reduction in endothelial density in both p53 wild-type and knockout animals, p53 +/+ and -/- spinal cord both showed albumin immunoreactivity around microvessels after XRT. We thus conclude that the acute BBB disruption after XRT is mediated by the ASMase but not the p53 pathway. These results suggest that oligodendroglial apoptosis is unlikely to play a critical role in the acute BBB disruption seen after XRT. This is consistent with the notion that astrocytes and microglia, but not oligodendrocytes, contribute to the formation of the BBB (37) .
Strategies that elevate cellular ceramide in the sphingomyelinase pathway in initiating XRT-induced apoptosis could be used for clinical radiotherapy aimed to promote apoptosis and improve tumor control. On the other hand, blockage of ceramide generation may protect some normal tissues from the side effects of radiotherapy. When basal fibroblast growth factor was given i.v. immediately before and after XRT, apoptosis was inhibited in endothelial cells in the lungs and mice were protected against the development of lethal XRT pneumonitis (12 , 38) . More recently, XRT-induced crypt damage, organ failure, and death from the gastrointestinal syndrome were prevented when endothelial apoptosis was inhibited by administration of i.v. basal fibroblast growth factor (13) .
For the CNS, our present results indicate that early apoptosis of the microvascular endothelial cell population initiates the development of acute BBB disruption after XRT. Targeting the sphingomyelinase/ceramide pathway may provide a basis for novel neuroprotective strategies. Disruption of the BBB by XRT also has implications in the treatment of primary and secondary brain tumors because it may influence drug delivery to the CNS (39 , 40) . Targeting XRT-induced endothelial apoptosis and the sphingomyelinase/ceramide pathway may thus be used to increase the permeability of the BBB to improve drug delivery.
| ACKNOWLEDGMENTS |
|---|
| FOOTNOTES |
|---|
1 Supported by the National Cancer Institute of Canada (C. S. W.) with funds from the Canadian Cancer Society. ![]()
2 To whom requests for reprints should be addressed, at Department of Radiation Oncology, Sunnybrook and Womens College Health Sciences Center, 2075 Bayview Avenue, Toronto, Ontario, M4N 3M5 Canada. Phone: (416) 480-4619; Fax: (416) 480-5737; E-mail: shun.wong{at}tsrcc.on.ca ![]()
3 The abbreviations used are: CNS, central nervous system; XRT, radiation treatment; BBB, bloodbrain barrier; ASMase, acid sphingomyelinase; NSMase, neutral sphingomyelinase; BSCB, blood-spinal cord barrier; TUNEL, terminal dUTP nicked end labeling; DAPI, 4,6-diamidino-2-phenylindole; DTPA, diethylenetriamine pentaacetic acid. ![]()
Received 4/11/03. Revised 6/ 9/03. Accepted 6/27/03.
| REFERENCES |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
Y. Cao, C. I. Tsien, P. C. Sundgren, V. Nagesh, D. Normolle, H. Buchtel, L. Junck, and T. S. Lawrence Dynamic Contrast-Enhanced Magnetic Resonance Imaging As a Biomarker for Prediction of Radiation-Induced Neurocognitive Dysfunction Clin. Cancer Res., March 1, 2009; 15(5): 1747 - 1754. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Wang, E. X. Wu, D. Qiu, L. H.T. Leung, H.-F. Lau, and P.-L. Khong Longitudinal Diffusion Tensor Magnetic Resonance Imaging Study of Radiation-Induced White Matter Damage in a Rat Model Cancer Res., February 1, 2009; 69(3): 1190 - 1198. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. L. Smith and E. H. Schuchman The unexpected role of acid sphingomyelinase in cell death and the pathophysiology of common diseases FASEB J, October 1, 2008; 22(10): 3419 - 3431. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Bonnaud, C. Niaudet, G. Pottier, M.-H. Gaugler, J. Millour, J. Barbet, L. Sabatier, and F. Paris Sphingosine-1-Phosphate Protects Proliferating Endothelial Cells from Ceramide-Induced Apoptosis but not from DNA Damage-Induced Mitotic Death Cancer Res., February 15, 2007; 67(4): 1803 - 1811. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J. Ohab, S. Fleming, A. Blesch, and S. T. Carmichael A Neurovascular Niche for Neurogenesis after Stroke J. Neurosci., December 13, 2006; 26(50): 13007 - 13016. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Gulbins and P. L. Li Physiological and pathophysiological aspects of ceramide Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2006; 290(1): R11 - R26. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Galimi, R. G. Summers, H. van Praag, I. M. Verma, and F. H. Gage A role for bone marrow-derived cells in the vasculature of noninjured CNS Blood, March 15, 2005; 105(6): 2400 - 2402. [Abstract] [Full Text] [PDF] |
||||
![]() |
J B Reitan, L Brinch, and K Beiske Multi-organ failure aspects of a fatal radiation accident in Norway in 1982 Br. J. Radiol., January 1, 2005; Supplement_27(1): 36 - 40. [Abstract] [Full Text] [PDF] |
||||
![]() |
M-H Gaugler A unifying system: does the vascular endothelium have a role to play in multi-organ failure following radiation exposure? Br. J. Radiol., January 1, 2005; Supplement 27(1): 100 - 105. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. S. Wong and A. J. Van der Kogel MECHANISMS OF RADIATION INJURY TO THE CENTRAL NERVOUS SYSTEM: IMPLICATIONS FOR NEUROPROTECTION Mol. Interv., October 1, 2004; 4(5): 273 - 284. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. S. Gregerson and H. Kawashima APC derived from donor splenocytes support retinal autoimmune disease in allogeneic recipients J. Leukoc. Biol., August 1, 2004; 76(2): 383 - 387. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |